The Pharmacy Times® Infectious Disease Resource Center is a comprehensive resource for clinical news and expert insights on a group of disorders caused by organisms, such as bacteria, viruses, fungi, or parasites.
January 22nd 2025
Pharmacists ensure responsible antibiotic use, combating resistance through tailored therapies.
January 14th 2025
Pneumococcal Disease Prevention for Older Adults and the Pharmacist’s Role in an Evolving Vaccine Landscape
1.0 Credit / Immunization, Infectious Diseases
View More
Navigating the HIV Treatment Frontier: Equipping Managed Care Professionals With Strategies for Innovation, Ac...
1.5 Credits / HIV/AIDS, Infectious Diseases
View More
The Impact of Pharmacists and Pharmacy Technicians in Recognizing and Responding to Human Trafficking (Pharmac...
2.0 Credits / Human Trafficking, Law
View More
Ensuring Pharmacy Technicians’ Proficiency in Risk Evaluation and Mitigation Strategies
1.0 Credit / Law, Pain Management, Opioids
View More
The Role of the Pharmacist in Influenza Prevention for At-Risk Adults: Strategies to Enhance Immunization
1.5 Credits / Infectious Diseases
View More
The Essential Role of Pharmacists in Improving Influenza Vaccination Coverage: Strategies to Increase Vaccine ...
1.0 Credit / Immunization, Infectious Diseases
View More
The Role of Pharmacists in Pneumococcal Prevention: Strategies to Improve Vaccine Uptake
1.0 Credit / Immunization, Infectious Diseases, Pulmonology
View More
Insights in Influenza Immunization: The Long-Term Care Pharmacist’s Role in Improving Health Outcomes in At-Ri...
1.0 Credit / Immunization, Infectious Diseases
View More
Second-Line Bedaquiline-Based Regimens Demonstrates Microbiological Response in Patients With TB
March 4th 2024The regimen, which was used as second-line treatment in patients with drug-resistant TB, had a similar microbiological response to those with drug-sensitive TB taking first-line regimens.
Read More
FDA Approves Isavuconazonium Sulfate to Treat Invasive Aspergillosis, Invasive Mucormycotic
December 8th 2023The approval marks isavuconazonium sulfate as the only granted azole antifungal therapy for pediatric patients with invasive aspergillosia and invasive mucormycotic who are as young as age 1.
Read More
Study Finds PrEP Boosts Confidence of Having HIV Transmission-Free Sex Among At-Risk Populations
October 11th 2023Pre-exposure prophylaxis found to provide peace of mind for patients at risk of HIV, and coupled with frequent HIV testing in the health care setting, lowers the perceived risk of contracting the disease.
Read More
Alcohol Consumption Not Found to Impact Sustained Virologic Response for Patients with Hepatitis C
October 3rd 2023The study investigators said that restricting access to direct-acting antiviral therapy due to alcohol consumption could create unnecessary barriers for those with hepatitis C virus.
Read More
Focus on Human Papillomavirus Virus Vaccination in Adults and Young Adults
September 18th 2023Combining strong evidence-based recommendations with caring, compassionate, and frequent counseling opportunities hopefully will increase vaccine acceptance and ultimately reduce the incidence of HPV and associated cancers among our patients.
Read More